Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...

You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...

Stifel analysts have maintained a Buy rating and a $28.00 price target for Phathom Pharmaceuticals (NASDAQ:PHAT), focusing on the company's recent developments. Currently trading at $5.59, ...

Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office has granted the company U.S. Patent No. 12,214,010, ...

Desmopressin is approved in various forms, but these do not meet the paediatric need for precise, titratable and small doses.

A man from Eloy has become the first rattlesnake bite case treated by Banner Health in 2025. Officials with the health system ...

A judge has dismissed a Seattle murder case against a prolific criminal accused of brutally beating a resident at a South ...

The Federal Circuit heard oral argument in Auribundo's appeal of the district court's decision in favor of plaintiff Merck, ...

Detectives in the Special Investigations Unit hit a home run with a big drug bust, according to the Orange Police Department. Two adults were arrrested and booked at the Orange County jail. Violating ...

Appellate courts issued a variety of notable intellectual property (IP) cases in 2024, including cases touching on Orange Book ...

If it’s published, the FDA is expected to propose language noting that “these chemicals are used in certain cosmetic products that are applied to human hair as part of a combination of ...